Financial Architects (New Jersey)’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Architects (New Jersey)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$16K	–	1456
2019 Q1	$16K	Hold	1,000	–	–	﹤0.01%	973
2018 Q4	$15K	Hold	1,000	–	–	﹤0.01%	894
2018 Q3	$22K	Buy	+1,000	New	+$23.2K	﹤0.01%	895
2018 Q2	–	Sell	-1,000	Closed	-$17K	–	1498
2018 Q1	$17K	Buy	+1,000	New	+$19.5K	﹤0.01%	928

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Financial Architects (New Jersey)'s TEVA Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 400 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in TEVA in Q2 2013 and held it in 29 quarters. The position peaked at $536K in Q4 2015. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Financial Architects (New Jersey) reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 400 Teva Pharmaceuticals shares in Q3 2020, an estimated $5K.
Financial Architects (New Jersey) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 29 quarters.
Financial Architects (New Jersey)'s Teva Pharmaceuticals position peaked at $536K in Q4 2015.
444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.